|
Featured Article
|
Getting The Most From Preclinical Imaging
By Patrick McConville, Ph.D., Life Science Leader magazine
The pharmaceutical industry continues to actively adopt imaging technologies to accelerate the drug discovery process. Imaging methods such as magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT), computed tomography (CT), and in vivo optical imaging offer important and valuable improvements over traditional drug discovery methods.
|
|
|
Top News Stories
|
Life Technologies Signs Definitive Agreement To Acquire AcroMetrix
Life Technologies Corporation, a provider of innovative life science solutions, today announced that it has signed a definitive agreement to acquire AcroMetrix, for an undisclosed amount.
|
TestAmerica Adds 6th Laboratory To DoD ELAP Accreditation List
TestAmerica's Seattle laboratory recently received their DoD ELAP accreditation under the Department of Defense Environmental Laboratory Approval Program (ELAP). The laboratory, located in Tacoma, Washington is now TestAmerica's sixth facility location to be accredited under the program.
|
Lantheus Medical Imaging, Inc. Launches ABLAVAR
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic imaging, recently announced the launch of ABLAVAR (gadofosveset trisodium), a unique, injectable MRA imaging agent used to evaluate aortoiliac occlusive disease (AIOD) in adults with known or suspected peripheral vascular disease (PVD).
|
St. Jude Medical Achieves Recognition For Security Of Patient Data And Completes Successful Testing To Streamline Connection To Patient Medical Records
St. Jude Medical, Inc. recently announced it has successfully completed its second interoperability testing process for the company's Merlin.net Patient Care Network, an Internet-based repository of patient and implantable device data.
|
iWorx Introduces A Suite Of Systems, Software And Components For Cardiovascular Research
iWorx, a developer of advanced physiology research and teaching tools, has launched a family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro.
|
Digital Proteomics On Next Generation Sequencers: Affomix And City Of Hope Announce Collaboration
Affomix Corporation, a pioneer in high performance antibody technology, announced recently a collaboration with City of Hope focused on establishing the clinical utility of "digital proteomics" with next generation sequencers.
|
Pall Corporation Acquires MicroReactor Technologies
Pall Corporation, a global leader in filtration, separation and purification, recently announced its acquisition of MicroReactor Technologies, Inc. (MRT), a privately held U.S. biotechnology company. MRT has developed a reliable, easy-to-use and cost-effective miniature bioreactor technology platform.
|
SeraCare Expands Quality Control And Manufacturing And Research Product Portfolio
SeraCare Life Sciences, Inc.,announced recently that the Company has added five new, differentiated products to its portfolio to meet the needs of SeraCare's growing customer base in the life sciences industry.
|
Ricerca Announces Validation Of Watson LIMS
Ricerca Biosciences is pleased to announce the validation and implementation of the Watson Laboratory Information Management System (LIMS) for the company's bioanalysis division.
|
Millipore Launches New Online MAb Bioprocess Sizing Tool
Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, has created an online MAb (monoclonal antibody) Bioprocess Sizing Tool to help biomanufacturing scientists and engineers develop and design filtration and chromatography processes.
|
|
|
|
|
|
|
|
|
|
|
|
Newsletter Subscription
|
|
If you do not currently receive the Laboratory Network.com newsletter and wish to become a subscriber,
click here.
|
|
|
Advertise Online
|
|
If you are interested in advertising with Laboratory Network.com, click here for more information.
|
|
|
RSS
